- 2023Pharmacological research10.1016/j.phrs.2023.106927
DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: A meta-analysis and systematic review.
- 2022The journal of pathology. Clinical research10.1002/cjp2.269
High cyclin E1 protein, but not gene amplification, is prognostic for basal-like breast cancer.
- 2021NPJ breast cancer10.1038/s41523-021-00312-x
Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition.